Φορτώνει......
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Thorax |
---|---|
Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
BMJ Publishing Group
2017
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5284333/ https://ncbi.nlm.nih.gov/pubmed/27852956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2016-208406 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|